Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-001550

Options or other derivatives

  • Chief Business - Strategy Off acquired 8,450 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lin Patrick Chief Business - Strategy Off 2026-07-26 Grant or award · Restricted Stock Units +8,450 11,389 D
Loading xslF345X06/form4.xml…